Pfizer snaps up rights to commercialize diabetes GLP-1 in China – Fierce Pharma
Looking to gain an edge as its broader obesity ambitions take shape, Pfizer has picked up the rights to a recently approved GLP-1 in China.Read More
The Heartbeat of World events
Looking to gain an edge as its broader obesity ambitions take shape, Pfizer has picked up the rights to a recently approved GLP-1 in China.Read More